CHANGMAO BIOCHEM-H-

BE:CZB Germany Other
Market Cap
$296.57
€288.92 EUR
Market Cap Rank
#49379 Global
#8301 in Germany
Share Price
€0.03
Change (1 day)
+0.00%
52-Week Range
€0.03 - €0.05
All Time High
€0.13
About

CHANGMAO BIOCHEM-H- operates in Diversified Metals & Mining.

CHANGMAO BIOCHEM-H- (CZB) - Total Liabilities

Latest total liabilities as of December 2023: €590.91 Million EUR

Based on the latest financial reports, CHANGMAO BIOCHEM-H- (CZB) has total liabilities worth €590.91 Million EUR as of December 2023.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

CHANGMAO BIOCHEM-H- - Total Liabilities Trend (2016–2023)

This chart illustrates how CHANGMAO BIOCHEM-H-'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

CHANGMAO BIOCHEM-H- Competitors by Total Liabilities

The table below lists competitors of CHANGMAO BIOCHEM-H- ranked by their total liabilities.

Company Country Total Liabilities
Altern Energy Ltd
KAR:ALTN
Pakistan PKRs6.03 Billion
Marechale Capital Plc
LSE:MAC
UK GBX123.20K
B-Scada Inc
PINK:SCDA
USA $74.72K
Evocati Capital Resources Inc.
V:EVOC-P
Canada CA$15.40K
Atok Big Wedge Co Inc
PSE:AB
Philippines ₱1.23 Million
Distil Plc
LSE:DIS
UK GBX951.00K
Bimi International Medical Inc
OTCMKTS:BIMI
USA $24.15 Million

Liability Composition Analysis (2016–2023)

This chart breaks down CHANGMAO BIOCHEM-H-'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.04 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.91 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.48 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CHANGMAO BIOCHEM-H-'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CHANGMAO BIOCHEM-H- (2016–2023)

The table below shows the annual total liabilities of CHANGMAO BIOCHEM-H- from 2016 to 2023.

Year Total Liabilities Change
2023-12-31 €590.91 Million +38.11%
2022-12-31 €427.86 Million +65.20%
2021-12-31 €258.99 Million +31.19%
2020-12-31 €197.41 Million +161.74%
2019-12-31 €75.42 Million -25.43%
2018-12-31 €101.15 Million -33.20%
2017-12-31 €151.43 Million +73.05%
2016-12-31 €87.50 Million --